This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| COVID-19 | 43344 |
| SARS | 27525 |
| ICU | 17356 |
| CoV-2 | 17015 |
| CT | 14070 |
| mg | 9955 |
| China | 8700 |
| T | 8203 |
| PCR | 7609 |
| C | 7161 |
| Hospital | 6689 |
| Health | 6542 |
| II | 5887 |
| ARDS | 5886 |
| • | 5801 |
| University | 5746 |
| MRI | 5567 |
| Wuhan | 5371 |
| Coronavirus | 5137 |
| HSCT | 5129 |
| CI | 4993 |
| B | 4941 |
| A | 4758 |
| S. | 4731 |
| Disease | 4569 |
| IL-6 | 4306 |
| RNA | 4292 |
| L | 4260 |
| Fig | 4182 |
| Table | 4159 |
| Care | 4043 |
| HIV | 3930 |
| COPD | 3827 |
| kg | 3817 |
| IV | 3768 |
| M. | 3740 |
| ED | 3716 |
| US | 3595 |
| ACE2 | 3534 |
| CoV | 3470 |
| Group | 3417 |
| ± | 3415 |
| Medical | 3392 |
| C. | 3385 |
| der | 3196 |
| United | 3180 |
| National | 3176 |
| HLA | 3156 |
| M | 3143 |
| Society | 3115 |
| CF | 3089 |
| March | 3049 |
| RT | 2996 |
| S | 2917 |
| J | 2908 |
| GVHD | 2890 |
| Clinical | 2859 |
| CMV | 2840 |
| CD4 | 2810 |
| January | 2806 |
| HCV | 2771 |
| States | 2743 |
| Department | 2730 |
| IFN | 2700 |
| CSF | 2680 |
| Center | 2646 |
| TNF | 2628 |
| MR | 2625 |
| HBV | 2584 |
| D | 2583 |
| Background | 2583 |
| E. | 2536 |
| P. | 2497 |
| AE | 2478 |
| A. | 2459 |
| MERS | 2444 |
| Study | 2434 |
| Medicine | 2411 |
| G | 2360 |
| ECMO | 2346 |
| sha | 2344 |
| PPE | 2343 |
| Italy | 2266 |
| USA | 2265 |
| American | 2265 |
| J. | 2253 |
| L. | 2246 |
| April | 2235 |
| CRP | 2224 |
| MS | 2191 |
| UK | 2171 |
| NK | 2159 |
| New | 2098 |
| CD8 | 2088 |
| Association | 2082 |
| III | 2068 |
| BMI | 2029 |
| Patient | 2017 |
| AKI | 1984 |
| December | 1978 |
| Institute | 1959 |
| IgG | 1918 |
| DOI | 1912 |
| RBC | 1910 |
| World | 1886 |
| F | 1859 |
| CFTR | 1848 |
| I | 1838 |
| Control | 1809 |
| Research | 1784 |
| MRSA | 1773 |
| IQR | 1773 |
| PD | 1772 |
| B. | 1753 |
| el | 1725 |
| Germany | 1691 |
| meta | 1685 |
| R. | 1676 |
| SCT | 1664 |
| May | 1661 |
| < | 1655 |
| Syndrome | 1645 |
| VAP | 1630 |
| fi | 1628 |
| H1N1 | 1607 |
| OS | 1595 |
| Organization | 1592 |
| K | 1580 |
| Intensive | 1577 |
| DNA | 1575 |
| Treatment | 1574 |
| G. | 1557 |
| Cancer | 1554 |
| IgM | 1549 |
| Case | 1544 |
| ELISA | 1537 |
| Patients | 1512 |
| D. | 1492 |
| COVID | 1482 |
| AML | 1481 |
| CNS | 1477 |
| H. | 1463 |
| International | 1459 |
| CD34 | 1457 |
| European | 1454 |
| K. | 1453 |
| PET | 1436 |
| France | 1433 |
| LPS | 1423 |
| Prevention | 1418 |
| Covid-19 | 1417 |
| signifi | 1412 |
| SD | 1405 |
| von | 1405 |
| TBI | 1400 |
| Japan | 1394 |
| E | 1389 |
| fl | 1385 |
| TB | 1379 |
| Management | 1375 |
| June | 1367 |
| Europe | 1360 |
| CA | 1350 |
| Staphylococcus | 1347 |
| February | 1342 |
| VTE | 1335 |
| mit | 1332 |
| U | 1326 |
| PE | 1325 |
| Emergency | 1315 |
| IgE | 1312 |
| Novel | 1303 |
| R | 1302 |
| EEG | 1299 |
| FDA | 1292 |
| HCC | 1280 |
| Committee | 1277 |
| Unit | 1266 |
| East | 1261 |
| Respiratory | 1259 |
| NIV | 1258 |
| System | 1251 |
| ICH | 1241 |
| Introduction | 1239 |
| Summary | 1230 |
| CDC | 1225 |
| IVIG | 1224 |
| Blood | 1224 |
| Review | 1219 |
| eine | 1216 |
| F. | 1212 |
| tocilizumab | 1211 |
| T. | 1208 |
| Diseases | 1208 |
| Objective | 1204 |
| EBV | 1204 |
| RSV | 1175 |
| range | 1170 |
| Hb | 1169 |
| Ebola | 1168 |
| IL-10 | 1168 |
| ECG | 1166 |
| N | 1163 |
| und | 1150 |
| HCQ | 1150 |
| GI | 1149 |
| Human | 1142 |
| Spain | 1137 |
| Children | 1136 |
| College | 1130 |
| York | 1129 |
| APACHE | 1129 |
| ¼ | 1114 |
| azithromycin | 1114 |
| HR | 1112 |
| IgA | 1104 |
| July | 1102 |
| Report | 1097 |
| CR | 1093 |
| IBD | 1091 |
| Middle | 1084 |
| Infectious | 1083 |
| RA | 1072 |
| MM | 1056 |
| remdesivir | 1054 |
| PA | 1054 |
| α | 1043 |
| bei | 1042 |
| mm | 1037 |
| ICP | 1028 |
| un | 1027 |
| GvHD | 1026 |
| Purpose | 1025 |
| N. | 1016 |
| CAP | 1002 |
| los | 997 |
| MD | 996 |
| LOS | 993 |
| AUC | 992 |
| General | 989 |
| mL | 988 |
| Guidelines | 987 |
| TM | 984 |
| America | 983 |
| GM | 981 |
| Pneumonia | 978 |
| Infection | 967 |
| SAH | 966 |
| IU | 962 |
| Pseudomonas | 961 |
| WHO | 950 |
| LV | 949 |
| Patienten | 944 |
| CD3 | 944 |
| SLE | 942 |
| P | 942 |
| WBC | 938 |
| nan | 937 |
| ATG | 930 |
| lymphopenia | 926 |
| September | 918 |
| min | 913 |
| des | 913 |
| ER | 912 |
| Use | 911 |
| H | 910 |
| India | 910 |
| Singapore | 908 |
| Assessment | 908 |
| South | 905 |
| Methods | 902 |
| BP | 893 |
| Pandemic | 890 |
| PCT | 886 |
| Korea | 886 |
| October | 884 |
| ABO | 880 |
| FDG | 879 |
| Hydroxychloroquine | 877 |
| Acute | 875 |
| Critical | 873 |
| ng | 871 |
| CC | 865 |
| hydroxychloroquine | 864 |
| CO | 862 |
| mRNA | 862 |
| ASCT | 859 |
| V | 857 |
| GCS | 857 |
| AR | 855 |
| sera | 853 |
| ml | 853 |
| DIC | 852 |
| IR | 851 |
| Analysis | 848 |
| AIDS | 847 |
| BM | 846 |
| CRS | 845 |
| Influenza | 844 |
| CKD | 843 |
| LDH | 839 |
| Heart | 838 |
| Fisher | 838 |
| Lung | 836 |
| City | 831 |
| dl | 827 |
| IL-8 | 827 |
| Pediatric | 826 |
| MV | 826 |
| Healthcare | 826 |
| Centre | 825 |
| IC | 820 |
| Evaluation | 818 |
| DC | 817 |
| I. | 815 |
| IL-1 | 812 |
| SP | 811 |
| ritonavir | 805 |
| August | 805 |
| pH | 801 |
| ROC | 796 |
| HCT | 795 |
| Hong | 794 |
| Australia | 790 |
| CVD | 783 |
| Turkey | 778 |
| HF | 775 |
| anti | 772 |
| MSC | 772 |
| CPAP | 771 |
| Risk | 769 |
| Imaging | 768 |
| Y | 764 |
| Foundation | 761 |
| November | 760 |
| EV | 750 |
| Candida | 750 |
| PT | 749 |
| del | 748 |
| defi | 748 |
| Centers | 747 |
| V. | 746 |
| para | 744 |
| Anti | 742 |
| T2 | 741 |
| Hodgkin | 737 |
| BAL | 736 |
| WT | 734 |
| TGF | 733 |
| con | 731 |
| Cox | 731 |
| Data | 728 |
| Drug | 728 |
| Kong | 721 |
| Mann | 720 |
| SPSS | 715 |
| HLH | 714 |
| FEV1 | 709 |
| einer | 707 |
| Studies | 702 |
| Med | 702 |
| PR | 701 |
| Whitney | 698 |
| Chronic | 698 |
| Canada | 698 |
| Figure | 696 |
| Pathology | 695 |
| Dr. | 695 |
| Trial | 691 |
| zu | 689 |
| IL | 689 |
| Surgery | 687 |
| ICUs | 685 |
| EVD | 685 |
| DR | 685 |
| Pulmonary | 684 |
| ATP | 683 |
| ed | 682 |
| werden | 681 |
| Doppler | 676 |
| Index | 676 |
| SCID | 676 |
| Safety | 674 |
| CD | 669 |
| Scale | 665 |
| ST | 665 |
| SCD | 665 |
| FEV | 665 |
| GBS | 663 |
| 8) | 663 |
| Chinese | 662 |
| Design | 662 |
| Wang | 661 |
| DVT | 661 |
| BMT | 660 |
| Africa | 660 |
| RIC | 658 |
| 3D | 654 |
| U.S. | 653 |
| IL-2 | 651 |
| ID | 650 |
| Cardiac | 650 |
| Therapy | 649 |
| vivo | 647 |
| North | 640 |
| HRCT | 639 |
| HAE | 639 |
| N95 | 633 |
| Li | 633 |
| Impact | 632 |
| VEGF | 628 |
| Score | 628 |
| multicentre | 627 |
| UTI | 627 |
| Remdesivir | 626 |
| MDS | 625 |
| Laboratory | 624 |
| monocyte | 623 |
| IPF | 618 |
| La | 617 |
| Conclusions | 617 |
| AP | 617 |
| mmol | 616 |
| RHD | 615 |
| RCT | 613 |
| NS | 610 |
| DM | 609 |
| RV | 609 |
| Virus | 608 |
| Netherlands | 607 |
| Outcomes | 606 |
| Transfusion | 603 |
| Oncology | 599 |
| OR | 596 |
| hepatitis | 594 |
| CAD | 594 |
| LC | 593 |
| SS | 593 |
| Service | 592 |
| BC | 592 |
| W. | 591 |
| bronchoalveolar | 589 |
| PICU | 589 |
| Administration | 589 |
| C1-INH | 588 |
| Cell | 587 |
| NHS | 587 |
| Network | 587 |
| School | 585 |
| EC | 584 |
| p<0.01 | 583 |
| infl | 583 |
| Science | 583 |
| London | 581 |
| Y. | 580 |
| MI | 580 |
| methotrexate | 578 |
| aGVHD | 570 |
| Commission | 570 |
| Development | 569 |
| Efficacy | 567 |
| VA | 566 |
| Registry | 566 |
| NIH | 565 |
| NC | 564 |
| GFR | 564 |
| Tocilizumab | 561 |
| en | 561 |
| Rh | 560 |
| Characteristics | 560 |
| PS | 559 |
| auf | 558 |
| Chen | 558 |
| MHC | 557 |
| Ethics | 557 |
| NHL | 556 |
| MRD | 555 |
| Clinic | 555 |
| Objectives | 554 |
| sich | 553 |
| miRNA | 553 |
| ACS | 552 |
| Asia | 550 |
| Brazil | 549 |
| Hubei | 545 |
| i.v | 545 |
| lopinavir | 544 |
| den | 543 |
| LMWH | 542 |
| anakinra | 541 |
| Republic | 541 |
| AF | 541 |
| pg | 539 |
| RR | 537 |
| CS | 536 |
| MAP | 535 |
| CoV-1 | 534 |
| Treg | 533 |
| State | 533 |
| CPR | 533 |
| ® | 532 |
| Glasgow | 532 |
| CTA | 532 |
| Chi | 531 |
| Crohn | 531 |
| FFP | 529 |
| MIC | 528 |
| ECP | 527 |
| PB | 525 |
| ALT | 525 |
| IL-4 | 524 |
| LT | 519 |
| Global | 518 |
| AST | 515 |
| PFS | 513 |
| Board | 513 |
| HIV-1 | 513 |
| CXR | 511 |
| _ | 510 |
| INR | 510 |
| DLI | 510 |
| medRxiv | 506 |
| CFU | 506 |
| þ | 506 |
| COVID‐19 | 503 |
| AA | 503 |
| Program | 502 |
| CoV2 | 500 |
| CVID | 498 |
| TCR | 496 |
| Sciences | 496 |
| Practice | 496 |
| PP | 495 |
| Public | 493 |
| NRM | 492 |
| ROS | 492 |
| WB | 491 |
| HC | 491 |
| SE | 490 |
| X | 487 |
| MA | 487 |
| Hepatitis | 487 |
| BD | 487 |
| ANOVA | 486 |
| England | 485 |
| Diagnosis | 485 |
| Services | 484 |
| Kingdom | 484 |
| SPECT | 483 |
| PID | 483 |
| Ministry | 483 |
| SC | 482 |
| du | 481 |
| PAH | 481 |
| ILD | 481 |
| novo | 479 |
| Klebsiella | 479 |
| HD | 478 |
| Community | 476 |
| Inc. | 475 |
| miRNAs | 475 |
| TMA | 474 |
| CPB | 474 |
| le | 473 |
| las | 471 |
| Effect | 471 |
| Cardiovascular | 471 |
| BCG | 469 |
| Taiwan | 467 |
| OBJECTIVES | 467 |
| nach | 467 |
| Council | 466 |
| Kawasaki | 465 |
| γ | 464 |
| TMPRSS2 | 464 |
| PBSC | 464 |
| EP | 463 |
| Kaplan | 462 |
| Epidemiology | 461 |
| PLT | 461 |
| pacientes | 461 |
| De | 460 |
| Chest | 460 |
| NSCLC | 459 |
| T1 | 456 |
| METHODS | 456 |
| ESRD | 455 |
| West | 454 |
| Central | 454 |
| VOD | 453 |
| interleukin-6 | 452 |
| CLL | 451 |
| Quality | 451 |
| Berlin | 450 |
| Zhang | 449 |
| ein | 448 |
| San | 448 |
| GC | 448 |
| ACE | 448 |
| Acinetobacter | 447 |
| Thoracic | 447 |
| PK | 443 |
| CRRT | 443 |
| CIDP | 443 |
| p<0.0001 | 442 |
| TA | 442 |
| Dept | 442 |
| AI | 441 |
| MTX | 441 |
| Na | 440 |
| Aim | 440 |
| CD19 | 439 |
| Asthma | 439 |
| lg | 438 |
| Radiology | 438 |
| HU | 437 |
| Cardiology | 437 |
| UC | 433 |
| VIII | 431 |
| Meier | 431 |
| es | 430 |
| disease | 429 |
| EGFR | 427 |
| Wilcoxon | 426 |
| APC | 426 |
| L1 | 425 |
| una | 423 |
| Consensus | 423 |
| selectin | 422 |
| ND | 422 |
| CML | 422 |
| Abstract | 421 |
| Greece | 421 |
| CGD | 420 |
| Plasma | 419 |
| LA | 419 |
| NP | 418 |
| ICG | 418 |
| − | 417 |
| prednisone | 417 |
| Cochrane | 417 |
| IRB | 416 |
| Ò | 416 |
| NAT | 416 |
| TRM | 415 |
| Support | 415 |
| OSA | 414 |
| amoxicillin | 410 |
| Royal | 410 |
| DWI | 410 |
| IA | 409 |
| ISS | 409 |
| NF | 408 |
| HRV | 408 |
| SIRS | 407 |
| Phase | 407 |
| MC | 407 |
| Lancet | 407 |
| Ill | 406 |
| HS | 406 |
| les | 405 |
| O. | 404 |
| Liver | 404 |
| SAPS | 404 |
| ES | 403 |
| Angiotensin | 403 |
| H7N9 | 402 |
| Nature | 401 |
| Creative | 400 |
| Hg | 399 |
| ned | 399 |
| mycophenolate | 398 |
| Trauma | 398 |
| Ca | 398 |
| Rapid | 397 |
| ALI | 396 |
| ESBL | 395 |
| EMS | 395 |
| EM | 395 |
| Commons | 395 |
| Organ | 394 |
| Chloroquine | 394 |
| S1 | 393 |
| MDCT | 393 |
| das | 392 |
| Clin | 391 |
| Day | 391 |
| Immunology | 391 |
| LUS | 391 |
| cm | 391 |
| identifi | 390 |
| Academy | 390 |
| MDR | 390 |
| airways | 389 |
| Transmission | 389 |
| CK | 389 |
| Mycobacterium | 388 |
| CP | 388 |
| ≤ | 388 |
| DSA | 388 |
| GP | 387 |
| Cov-2 | 387 |
| BY | 387 |
| ASA | 386 |
| zur | 385 |
| Journal | 385 |
| Legionella | 384 |
| Brain | 383 |
| PI | 383 |
| CQ | 383 |
| AC | 382 |
| Iran | 382 |
| Q | 380 |
| NT | 379 |
| Province | 378 |
| Paris | 378 |
| Force | 377 |
| Meta | 376 |
| ARF | 376 |
| antiphospholipid | 376 |
| Roche | 376 |
| Se | 376 |
| SR | 375 |
| Systems | 374 |
| HSV | 373 |
| CABG | 373 |
| Working | 373 |
| NGS | 373 |
| CRC | 372 |
| PPV | 371 |
| Guillain | 371 |
| Liu | 370 |
| Faculty | 370 |
| PubMed | 369 |
| ITP | 369 |
| doc_id | 367 |
| Escherichia | 367 |
| BSI | 367 |
| Red | 367 |
| Springer | 366 |
| FC | 366 |
| CVC | 366 |
| HL | 365 |
| Ergebnisse | 365 |
| Food | 365 |
| Le | 365 |
| NLR | 365 |
| m2 | 365 |
| Regional | 364 |
| CE | 364 |
| HA | 363 |
| Lee | 362 |
| BNP | 362 |
| rst | 361 |
| Task | 361 |
| Molecular | 361 |
| Stroke | 360 |
| IL-5 | 360 |
| ICS | 360 |
| EBMT | 359 |
| MAC | 359 |
| Medicare | 359 |
| Therapie | 359 |
| Guidance | 358 |
| Failure | 358 |
| Tregs | 358 |
| Transplant | 358 |
| PSA | 356 |
| IL-12 | 356 |
| ms | 356 |
| Streptococcus | 356 |
| SA | 355 |
| IHC | 355 |
| ADC | 355 |
| Scientific | 354 |
| nd | 353 |
| einem | 353 |
| TCD | 353 |
| st | 352 |
| Hospitalized | 352 |
| Detection | 352 |
| High | 351 |
| EU | 351 |
| Pearson | 351 |
| sec | 351 |
| Viral | 350 |
| Team | 350 |
| association | 349 |
| Recommendations | 349 |
| Life | 349 |
| DE | 348 |
| CMT | 348 |
| MRA | 347 |
| GA | 347 |
| CD14 | 347 |
| cGVHD | 346 |
| SBP | 346 |
| AT | 346 |
| NICU | 345 |
| mofetil | 344 |
| Lombardy | 344 |
| Distress | 344 |
| JIA | 344 |
| ammatory | 344 |
| VT | 344 |
| W | 344 |
| Telemedicine | 343 |
| MMF | 343 |
| pts | 342 |
| Washington | 342 |
| Epstein | 342 |
| Toronto | 341 |
| Alzheimer | 341 |
| AB | 341 |
| × | 340 |
| Transplantation | 339 |
| HP | 339 |
| RRT | 338 |
| Immune | 338 |
| μg | 338 |
| Neutrophil | 337 |
| People | 336 |
| VUR | 335 |
| TCZ | 335 |
| AL | 335 |
| MT | 334 |
| IL-17 | 334 |
| Ab | 334 |
| PEEP | 333 |
| California | 333 |
| Americans | 333 |
| alfa | 331 |
| Switzerland | 331 |
| AIS | 331 |
| Parkinson | 330 |
| Barr | 330 |
| parainfluenza | 330 |
| Cy | 329 |
| COVID19 | 329 |
| nicht | 329 |
| Pneumocystis | 329 |
| Spearman | 329 |
| Ig | 328 |
| HFNC | 328 |
| HAART | 328 |
| CB | 328 |
| C3 | 328 |
| β | 327 |
| Conclusion | 327 |
| Associated | 327 |
| Technology | 326 |
| HSC | 326 |
| C1 | 326 |
| Project | 325 |
| Neurology | 325 |
| VAS | 324 |
| Siemens | 324 |
| colistin | 324 |
| STEMI | 323 |
| Supplementary | 323 |
| Response | 322 |
| Protein | 322 |
| PD-1 | 322 |
| covid-19 | 321 |
| GERD | 321 |
| ESR | 320 |
| Non | 320 |
| tPA | 319 |
| Les | 319 |
| Der | 319 |
| Azithromycin | 319 |
| Surgical | 318 |
| DS | 317 |
| Effectiveness | 317 |
| MP | 317 |
| HH | 317 |
| Student | 317 |
| effi | 316 |
| Michael | 316 |
| MSD | 316 |
| Israel | 316 |
| Infections | 316 |
| EN | 315 |
| First | 314 |
| EVs | 314 |
| Survey | 314 |
| Hematology | 314 |
| Lopinavir | 314 |
| TEG | 313 |
| Surg | 313 |
| SNP | 313 |
| Enterobacteriaceae | 311 |
| Guideline | 311 |
| Kg | 311 |
| Yang | 310 |
| VRE | 310 |
| ACE-2 | 310 |
| AECOPD | 309 |
| ASM | 309 |
| Act | 309 |
| ET | 309 |
| JAK | 309 |
| MOF | 309 |
| Saudi | 309 |
| ou | 309 |
| PaO | 308 |
| Ireland | 308 |
| IL-18 | 308 |
| HRS | 308 |
| FA | 307 |
| Agency | 307 |
| por | 307 |
| NE | 306 |
| Kim | 306 |
| David | 306 |
| | | 306 |
| T2DM | 305 |
| INTRODUCTION | 305 |
| HPV | 305 |
| ward | 304 |
| RI | 304 |
| ADA | 304 |
| PH | 303 |
| Chlamydia | 303 |
| Primary | 301 |
| Huang | 301 |
| MDA | 301 |
| Belgium | 301 |
| Thomas | 301 |
| group | 301 |
| imipenem | 301 |
| mmHg | 300 |
| Randomized | 300 |
| Dr | 300 |
| CHB | 300 |
| ist | 299 |
| PTSD | 299 |
| ICC | 297 |
| OA | 297 |
| Tc | 297 |
| anterior | 296 |
| Test | 296 |
| PMN | 296 |
| como | 295 |
| TLR | 295 |
| IVC | 295 |
| CDI | 295 |
| Gram | 294 |
| BOS | 294 |
| IM | 294 |
| e. | 294 |
| TT | 294 |
| SOS | 294 |
| max | 293 |
| IT | 293 |
| Factor | 293 |
| LAM | 292 |
| CHD | 292 |
| administration | 292 |
| au | 292 |
| oseltamivir | 292 |
| Cross | 291 |
| AMI | 291 |
| ne | 291 |
| Institutional | 290 |
| AG | 290 |
| FVC | 289 |
| DFS | 289 |
| Standard | 289 |
| durch | 289 |
| CONCLUSION | 288 |
| -3 | 288 |
| Allergy | 288 |
| RCC | 288 |
| ME | 288 |
| nan | 288 |
| Post | 288 |
| ~ | 287 |
| hs | 287 |
| PCP | 287 |
| H5N1 | 287 |
| Results | 286 |
| HAA | 286 |
| specifi | 285 |
| St. | 285 |
| QT | 285 |
| MCP-1 | 285 |
| Jan | 285 |
| Adults | 284 |
| ANCA | 284 |
| qPCR | 284 |
| GE | 284 |
| Northern | 284 |
| uenza | 283 |
| TC | 283 |
| EDs | 283 |
| Type | 282 |
| Austria | 282 |
| Arabia | 282 |
| BK | 281 |
| DAT | 281 |
| Helsinki | 281 |
| Kidney | 281 |
| TLR4 | 280 |
| Information | 280 |
| Cl | 280 |
| Box | 280 |
| Article | 280 |
| LVEF | 279 |
| CSA | 279 |
| HER2 | 279 |
| colchicine | 279 |
| Severe | 279 |
| T3 | 279 |
| scan | 279 |
| DI | 278 |
| van | 277 |
| SEM | 277 |
| NKT | 277 |
| KO | 277 |
| Gy | 277 |
| CVP | 277 |
| auch | 276 |
| Mycoplasma | 276 |
| Chicago | 276 |
| DAD | 275 |
| IL-1β | 275 |
| John | 275 |
| Leydig | 275 |
| Protocol | 275 |
| Trials | 275 |
| Salmonella | 275 |
| FACS | 274 |
| wurde | 273 |
| Zealand | 273 |
| SDS | 273 |
| MAS | 273 |
| Institutes | 273 |
| 2D | 273 |
| Sepsis | 272 |
| LD | 272 |
| Fibrosis | 272 |
| Ann | 272 |
| KD | 271 |
| RFA | 270 |
| AS | 270 |
| Rituximab | 270 |
| Surgeons | 270 |
| QOL | 269 |
| PEG | 269 |
| Learning | 269 |
| British | 269 |
| El | 268 |
| HPA | 268 |
| PBMC | 268 |
| RAS | 268 |
| Systematic | 268 |
| Time | 268 |
| mTOR | 268 |
| oder | 267 |
| Shanghai | 267 |
| RCTs | 267 |
| Coma | 266 |
| Barré | 266 |
| CFS | 266 |
| Wu | 266 |
| Division | 266 |
| PAI-1 | 266 |
| MPO | 266 |
| Microbiology | 265 |
| HPLC | 265 |
| Appendix | 265 |
| APS | 265 |
| neuro | 264 |
| SMA | 264 |
| RD | 264 |
| HE | 264 |
| EHR | 264 |
| Danshen | 264 |
| Maria | 263 |
| Enterococcus | 263 |
| French | 263 |
| Madrid | 263 |
| enoxaparin | 263 |
| eff | 263 |
| n=10 | 263 |
| Al | 262 |
| ACR | 261 |
| Thrombosis | 261 |
| EPO | 261 |
| EMR | 261 |
| CBT | 261 |
| control | 260 |
| HDL | 260 |
| GGO | 260 |
| Beijing | 260 |
| Consortium | 259 |
| PTLD | 259 |
| AEs | 259 |
| ERCP | 259 |
| DCs | 259 |
| Sweden | 259 |
| VZV | 259 |
| linezolid | 259 |
| Tx | 259 |
| p= | 258 |
| TH | 258 |
| Pharmacy | 258 |
| Bone | 258 |
| Adult | 258 |
| IVIg | 257 |
| alloSCT | 257 |
| baumannii | 256 |
| TF | 256 |
| MNC | 256 |
| Abbott | 256 |
| Renal | 255 |
| DCI | 255 |
| COV-2 | 255 |
| Fc | 254 |
| Interest | 254 |
| PO | 253 |
| Early | 253 |
| Confl | 253 |
| Bei | 253 |
| ASL | 253 |
| Th17 | 253 |
| Italian | 252 |
| Ag | 252 |
| PTH | 252 |
| TRALI | 251 |
| S2 | 251 |
| HAP | 251 |
| CH | 251 |
| CD56 | 251 |
| methylprednisolone | 250 |
| melphalan | 250 |
| HEPA | 250 |
| Education | 250 |
| Cystic | 249 |
| g. | 249 |
| EF | 248 |
| multiorgan | 247 |
| ciency | 247 |
| NAC | 247 |
| Injury | 247 |
| Head | 247 |
| Pediatrics | 246 |
| Ankara | 246 |
| benefi | 245 |
| TE | 245 |
| RBD | 245 |
| NAFLD | 245 |
| AM | 245 |
| Protection | 244 |
| OC43 | 244 |
| ALF | 243 |
| IMV | 243 |
| Low | 243 |
| veno | 243 |
| Receptor | 243 |
| Stem | 242 |
| SOFA | 242 |
| SVR | 241 |
| G2 | 241 |
| Extracellular | 241 |
| ABSTRACT | 241 |
| TTE | 240 |
| P<0.001 | 240 |
| HES | 240 |
| Diagnostics | 240 |
| CV | 240 |
| CMR | 240 |
| A2 | 240 |
| Seattle | 239 |
| PFGE | 239 |
| TG | 239 |
| une | 239 |
| p=0.01 | 238 |
| Union | 238 |
| PN | 237 |
| CD25 | 237 |
| Model | 236 |
| CTPA | 236 |
| EMT | 236 |
| Johnson | 236 |
| SF | 236 |
| SI | 236 |
| SpO2 | 236 |
| confi | 236 |
| biopsy | 235 |
| Dis | 235 |
| CR1 | 234 |
| Diagnostic | 234 |
| Government | 234 |
| Mental | 234 |
| p=0.001 | 234 |
| Norway | 234 |
| als | 233 |
| Telehealth | 233 |
| NIHSS | 233 |
| Grade | 233 |
| Gene | 233 |
| GR | 233 |
| PBS | 232 |
| Cohort | 232 |
| Martin | 232 |
| Xu | 232 |
| Physiology | 232 |
| Tokyo | 232 |
| meropenem | 231 |
| Zika | 231 |
| BALB | 230 |
| ACEI | 230 |
| GSH | 230 |
| CCI | 230 |
| IBM | 230 |
| ∆F508 | 229 |
| Method | 229 |
| G1 | 229 |
| allo | 229 |
| PSV | 229 |
| Willebrand | 229 |
| piperacillin | 228 |
| ont | 228 |
| myeloablative | 228 |
| Zhou | 228 |
| NSAIDs | 228 |
| GH | 228 |
| English | 228 |
| chi | 227 |
| LP | 227 |
| Questionnaire | 226 |
| ENT | 226 |
| ANC | 226 |
| NOS | 226 |
| Thailand | 226 |
| antigen | 226 |
| sind | 225 |
| Region | 225 |
| IL-13 | 225 |
| BCR | 225 |
| Athens | 225 |
| HCWs | 224 |
| Hospitals | 224 |
| Social | 224 |
| wird | 223 |
| inotropic | 223 |
| Ultrasound | 223 |
| HBoV | 223 |
| ARB | 223 |
| FM | 222 |
| Flu | 222 |
| HT | 222 |
| MCA | 222 |
| Marie | 222 |
| Yu | 222 |
| dem | 221 |
| VR | 221 |
| Th | 221 |
| TP | 221 |
| Statement | 221 |
| CVVH | 221 |
| Advisory | 221 |
| SEP | 220 |
| HbA1c | 220 |
| Declaration | 220 |
| BALF | 220 |
| SAA | 219 |
| Antimicrobial | 219 |
| CTC | 219 |
| MSCT | 219 |
| Schlussfolgerungen | 219 |
| imaging | 219 |
| TPE | 219 |
| Gd | 218 |
| ESC | 218 |
| G6PD | 218 |
| ECM | 218 |
| JP | 218 |
| Russia | 218 |
| Surveillance | 218 |
| bp | 217 |
| UCB | 217 |
| Monitoring | 217 |
| FP | 217 |
| Convalescent | 217 |
| ANA | 217 |
| CD16 | 216 |
| Internal | 216 |
| U. | 216 |
| Western | 216 |
| Z. | 216 |
| SAS | 215 |
| Lin | 215 |
| CoVs | 215 |
| Lu | 214 |
| CRF | 214 |
| Classification | 214 |
| HBsAg | 214 |
| OLT | 214 |
| OP | 214 |
| Trust | 214 |
| uso | 214 |
| Robert | 213 |
| O | 213 |
| MRC | 213 |
| IPC | 213 |
| Factors | 213 |
| Bcl-2 | 212 |
| Access | 212 |
| Ang | 212 |
| SM | 212 |
| Denmark | 212 |
| HOMA | 212 |
| QTc | 211 |
| OHCA | 211 |
| Accepted | 211 |
| tacrolimus | 210 |
| infi | 210 |
| Thrombocytopenia | 210 |
| Texas | 210 |
| PCI | 210 |
| Findings | 210 |
| CD45 | 210 |
| ATS | 209 |
| Expert | 209 |
| Mexico | 209 |
| Young | 209 |
| trimethoprim | 209 |
| Rehabilitation | 208 |
| MAPK | 208 |
| LPV | 208 |
| Joint | 208 |
| HHV-6 | 208 |
| AFP | 208 |
| IFI | 207 |
| BV | 207 |
| HCoV | 207 |
| n= | 207 |
| Philadelphia | 207 |
| VI | 207 |
| ACC | 206 |
| BRAF | 206 |
| CM | 206 |
| Coronaviruses | 206 |
| HEV | 206 |
| Physicians | 206 |
| IDSA | 206 |
| da | 205 |
| RFID | 205 |
| Note | 205 |
| CPT | 205 |
| BA | 205 |
| CL | 204 |
| A1 | 204 |
| ACT | 204 |
| Boston | 204 |
| sowie | 204 |
| NEC | 204 |
| NPV | 204 |
| PRES | 204 |
| ABC | 203 |
| MRS | 203 |
| UFH | 203 |
| Nephrology | 203 |
| STAT3 | 202 |
| HSP | 202 |
| Canadian | 202 |
| Family | 202 |
| SG | 202 |
| Jean | 202 |
| NY | 202 |
| PHT | 201 |
| Neurological | 201 |
| NTA | 201 |
| Child | 201 |
| CD20 | 201 |
| Office | 201 |
| NCCLS | 200 |
| Bio | 200 |
| Di | 200 |
| EDTA | 200 |
| Es | 200 |
| Van | 200 |
| bortezomib | 200 |
| haplo | 200 |
| ammation | 200 |
| ZIKV | 199 |
| RP | 199 |
| County | 199 |
| CTL | 199 |
| Portugal | 198 |
| Laparoscopic | 198 |
| Poland | 198 |
| dL | 198 |
| Reporting | 198 |
| post | 198 |
| Panel | 197 |
| NHMRC | 197 |
| Age | 196 |
| CRT | 196 |
| Long | 196 |
| Milan | 196 |
| Pts | 196 |
| TKI | 196 |
| Rheumatology | 196 |
| einen | 195 |
| bis | 195 |
| T4 | 195 |
| SB | 195 |
| IP-10 | 195 |
| Genetics | 195 |
| Cr | 195 |
| Akt | 195 |
| Digital | 194 |
| BL | 194 |
| Based | 194 |
| CBF | 194 |
| BS | 194 |
| ROI | 194 |
| non | 194 |
| −1 | 194 |
| Units | 194 |
| cytomegalovirus | 193 |
| PCA | 193 |
| Medicaid | 193 |
| Dental | 193 |
| Charlson | 193 |
| ACTH | 193 |
| CHF | 192 |
| Bu | 192 |
| CG | 192 |
| tele | 192 |
| HDM | 192 |
| Ki67 | 192 |
| ADP | 191 |
| AHA | 191 |
| Airway | 191 |
| Features | 191 |
| MELD | 191 |
| Marrow | 191 |
| Ritonavir | 191 |
| P1 | 191 |
| recomienda | 190 |
| Wistar | 190 |
| VO | 190 |
| SV | 190 |
| Pleural | 190 |
| Mortality | 190 |
| FiO | 190 |
| Dexamethasone | 190 |
| DMSO | 190 |
| CNI | 190 |
| p<0.05 | 190 |
| IE | 189 |
| CD10 | 189 |
| GBM | 189 |
| GT | 189 |
| SPT | 189 |
| Nil | 189 |
| Open | 189 |
| TP53 | 189 |
| Z | 189 |
| MMP-2 | 188 |
| Federation | 188 |
| GmbH | 188 |
| HSA | 188 |
| ICAM-1 | 188 |
| M1 | 188 |
| FVIII | 188 |
| Ontario | 188 |
| Sanger | 188 |
| TSH | 188 |
| VS | 188 |
| PCC | 188 |
| series | 188 |
| Survival | 187 |
| CPP | 187 |
| Corona | 187 |
| Istanbul | 187 |
| ug | 187 |
| TLR2 | 187 |
| Ventilator | 187 |
| patient | 187 |
| su | 187 |
| Text | 186 |
| TS | 186 |
| SOD | 186 |
| Paul | 186 |
| Nutrition | 186 |
| Anakinra | 185 |
| Antibody | 185 |
| Colchicine | 185 |
| PTA | 185 |
| PVL | 185 |
| SAE | 185 |
| SF-36 | 185 |
| SpO | 185 |
| TR | 185 |
| n=6 | 185 |
| TOF | 184 |
| TAC | 184 |
| SNPs | 184 |
| RAAS | 184 |
| MBL | 184 |
| HCP | 184 |
| German | 184 |
| Eastern | 184 |
| Activity | 184 |
| ClinicalTrials.gov | 183 |
| HFD | 183 |
| C2 | 183 |
| Cytomegalovirus | 183 |
| Barcelona | 183 |
| PIP | 183 |
| Tg | 183 |
| sulfamethoxazole | 183 |
| Sertoli | 183 |
| h. | 182 |
| Los | 182 |
| LH | 182 |
| Ki-67 | 182 |
| GS | 182 |
| Director | 182 |
| CD63 | 182 |
| EFS | 181 |
| C4 | 181 |
| EE | 181 |
| Spanish | 181 |
| GNB | 181 |
| Inhibitors | 181 |
| ICI | 180 |
| BI | 180 |
| CMS | 180 |
| Das | 180 |
| Fas | 180 |
| Graves | 180 |
| Preoperative | 180 |
| Int | 180 |
| MG | 180 |
| Pediatr | 180 |
| SJS | 180 |
| UIP | 180 |
| mcg | 180 |
| chloroquine | 179 |
| analysis | 179 |
| Wales | 179 |
| TEM | 179 |
| Enterobacter | 179 |
| CO2 | 179 |
| BKV | 179 |
| MB | 178 |
| FSGS | 178 |
| Hz | 178 |
| IAT | 178 |
| dieser | 178 |
| sarilumab | 178 |
| siRNA | 178 |
| King | 177 |
| Attribution | 177 |
| Coagulopathy | 177 |
| KS | 177 |
| Aerosol | 177 |
| Pa | 177 |
| Standards | 177 |
| Wallis | 177 |
| square | 177 |
| Peter | 176 |
| GFP | 176 |
| DA | 176 |
| Bland | 176 |
| Bank | 176 |
| APTT | 176 |
| TREC | 175 |
| Grant | 175 |
| Single | 175 |
| committee | 175 |
| tachypnea | 175 |
| aneurysmal | 175 |
| lo | 175 |
| wurden | 175 |
| health | 174 |
| cient | 174 |
| Statistical | 174 |
| Smith | 174 |
| SN | 174 |
| Pressure | 174 |
| Park | 174 |
| IP | 174 |
| Finland | 174 |
| Database | 174 |
| AMR | 174 |
| CAM | 173 |
| Critically | 173 |
| Rome | 173 |
| BEAM | 173 |
| DD | 173 |
| general | 173 |
| Short | 173 |
| airway | 173 |
| metformin | 173 |
| Testing | 173 |
| Kell | 172 |
| ALK | 172 |
| CAR | 172 |
| Bangladesh | 172 |
| MIS | 172 |
| buffy | 172 |
| diff | 172 |
| p=0.003 | 172 |
| Xa | 171 |
| BT | 171 |
| CsA | 171 |
| Donor | 171 |
| ETT | 171 |
| Heparin | 171 |
| MODS | 171 |
| Observational | 171 |
| kB | 171 |
| chez | 171 |
| etanercept | 171 |
| il | 171 |
| mL. | 171 |
| p=0.002 | 171 |
| ruxolitinib | 171 |
| thromboplastin | 171 |
| IL-7 | 170 |
| EMA | 170 |
| Eine | 170 |
| Hopkins | 170 |
| BPD | 170 |
| LR | 170 |
| RM | 170 |
| SEC | 170 |
| Univariate | 170 |
| Mayo | 170 |
| James | 169 |
| AIHA | 169 |
| Charcot | 169 |
| MTT | 169 |
| SBT | 169 |
| Vienna | 169 |
| empyema | 169 |
| Lymphoma | 168 |
| Anesthesia | 168 |
| DTPA | 168 |
| HAI | 168 |
| Investigator | 168 |
| DLBCL | 168 |
| Physical | 168 |
| est | 168 |
| heparin | 168 |
| neurocritical | 168 |
| acyclovir | 168 |
| SDH | 167 |
| CBC | 167 |
| CoV. | 167 |
| 167 | |
| PAC | 167 |
| Procalcitonin | 167 |
| RF | 167 |
| SUV | 167 |
| Screening | 167 |
| TLC | 167 |
| dans | 167 |
| department | 167 |
| lung | 167 |
| IX | 166 |
| AHSCT | 166 |
| BBB | 166 |
| C4d | 166 |
| CTX | 166 |
| HRQoL | 166 |
| n=12 | 166 |
| MCI | 166 |
| NG | 166 |
| Novartis | 166 |
| QC | 166 |
| Seoul | 166 |
| MCS | 166 |
| Function | 165 |
| BW | 165 |
| CEA | 165 |
| CY | 165 |
| DCM | 165 |
| ADL | 165 |
| GOS | 165 |
| Kruskal | 165 |
| MPA | 165 |
| anesthesia | 165 |
| eines | 165 |
| Gruppe | 165 |
| FL | 164 |
| BTK | 164 |
| Baseline | 164 |
| CD40 | 164 |
| DAH | 164 |
| PHA | 164 |
| Practices | 164 |
| TTP | 164 |
| i | 164 |
| AIT | 163 |
| Altman | 163 |
| HUS | 163 |
| INH | 163 |
| MF | 163 |
| Series | 163 |
| Sequential | 163 |
| MSI | 163 |
| Statistics | 163 |
| author(s | 163 |
| corpus | 163 |
| für | 163 |
| jirovecii | 163 |
| lavage | 163 |
| Therapeutics | 163 |
| été | 162 |
| NCS | 162 |
| M2 | 162 |
| HTLV | 162 |
| Breast | 162 |
| Intravenous | 161 |
| CLP | 161 |
| George | 161 |
| IL-15 | 161 |
| Hemodynamic | 161 |
| MFI | 161 |
| konnte | 161 |
| sont | 161 |
| Pathogenesis | 161 |
| Investigation | 160 |
| ALS | 160 |
| CpG | 160 |
| Herpes | 160 |
| IB | 160 |
| Initiative | 160 |
| KRAS | 160 |
| Methodik | 160 |
| NBS | 160 |
| p=0.04 | 160 |
| qRT | 160 |
| AED | 159 |
| B19 | 159 |
| CME | 159 |
| HCW | 159 |
| Inc | 159 |
| Interleukin-6 | 159 |
| MIC90 | 159 |
| VII | 159 |
| aplasia | 159 |
| Multiple | 159 |
| TACE | 159 |
| PV | 159 |
| Interferon | 158 |
| AHR | 158 |
| C57BL/6 | 158 |
| FS | 158 |
| Illumina | 158 |
| FR | 158 |
| LVAD | 158 |
| MPS | 158 |
| TX | 158 |
| metapneumovirus | 158 |
| microangiopathy | 158 |
| Illness | 157 |
| ASD | 157 |
| Ara | 157 |
| Australian | 157 |
| Class | 157 |
| EA | 157 |
| Helicobacter | 157 |
| Philips | 157 |
| LDL | 157 |
| Mass | 157 |
| Performance | 157 |
| S3 | 157 |
| classifi | 157 |
| lymphocytopenia | 157 |
| Vero | 157 |
| Oxford | 156 |
| 16S | 156 |
| CEUS | 156 |
| DTI | 156 |
| ICA | 156 |
| Lewis | 156 |
| Paulo | 156 |
| Serbia | 156 |
| alloHSCT | 156 |
| haemodialysis | 156 |
| interferon | 156 |
| Studie | 156 |
| Favipiravir | 155 |
| -5 | 155 |
| Area | 155 |
| Baricitinib | 155 |
| Chang | 155 |
| Interim | 155 |
| Percutaneous | 155 |
| Russian | 155 |
| cas | 155 |
| dass | 155 |
| n=5 | 155 |
| über | 155 |
| NGAL | 154 |
| ASC | 154 |
| Biology | 154 |
| IHD | 154 |
| MSSA | 154 |
| Mechanisms | 154 |
| mean | 154 |
| OCS | 154 |
| OCT | 154 |
| WES | 154 |
| acid | 154 |
| favipiravir | 154 |
| SSI | 153 |
| Asian | 153 |
| P2 | 153 |
| PG | 153 |
| POC | 153 |
| Retrospective | 153 |
| Serum | 153 |
| syndrome | 153 |
| cTnI | 153 |
| kann | 153 |
| Sun | 153 |
| arthroplasty | 153 |
| ohne | 152 |
| gd | 152 |
| Vt | 152 |
| SOC | 152 |
| PGE2 | 152 |
| Nursing | 152 |
| MMP-9 | 152 |
| Cytokine | 152 |
| Plan | 152 |
| Collaborative | 151 |
| ADHD | 151 |
| Assay | 151 |
| COVID-2019 | 151 |
| ECOG | 151 |
| Histologic | 151 |
| IVH | 151 |
| MUD | 151 |
| preprint | 150 |
| m² | 150 |
| Women | 150 |
| PMA | 150 |
| NAI | 150 |
| Level | 150 |
| Adenovirus | 150 |
| ADR | 149 |
| Corticosteroids | 149 |
| Cyclophosphamide | 149 |
| EB | 149 |
| Kupffer | 149 |
| NR | 149 |
| PNS | 149 |
| Training | 149 |
| mucositis | 149 |
| p=0.02 | 149 |
| thrombi | 149 |
| ventilación | 149 |
| zum | 149 |
| d'une | 149 |
| PUI | 148 |
| Body | 148 |
| Diabetes | 148 |
| Francisco | 148 |
| ITU | 148 |
| LS | 148 |
| Mediterranean | 148 |
| Outbreak | 148 |
| Neck | 148 |
| SSP | 148 |
| Version | 148 |
| X. | 148 |
| catarrhalis | 148 |
| p>0.05 | 148 |
| par | 148 |
| trans | 148 |
| VCAM-1 | 148 |
| PIDD | 147 |
| Allo | 147 |
| Immunodeficiency | 147 |
| Neuro | 147 |
| puede | 147 |
| Prediction | 147 |
| Supplemental | 147 |
| di | 147 |
| refl | 147 |
| CLD | 146 |
| CD31 | 146 |
| ECLS | 146 |
| DP | 146 |
| neutrophilia | 146 |
| Immunohistochemistry | 146 |
| Publisher | 146 |
| ser | 146 |
| KDIGO | 146 |
| Host | 145 |
| BTS | 145 |
| Cheng | 145 |
| Criteria | 145 |
| Egypt | 145 |
| Eur | 145 |
| GPA | 145 |
| Japanese | 145 |
| TTM | 145 |
| UI | 145 |
| Vascular | 145 |
| lymphohistiocytosis | 145 |
| mass | 145 |
| κB | 145 |
| Pharma | 144 |
| Activation | 144 |
| CD36 | 144 |
| Controlled | 144 |
| EIA | 144 |
| EMG | 144 |
| GN | 144 |
| ADEM | 144 |
| Pharmaceuticals | 144 |
| SCC | 144 |
| Tang | 144 |
| Tomography | 144 |
| Ventilation | 144 |
| appendix | 144 |
| mittels | 144 |
| Position | 144 |
| Fludarabine | 143 |
| -1 | 143 |
| CHU | 143 |
| Charles | 143 |
| Conference | 143 |
| Dimer | 143 |
| MIBI | 143 |
| TNFa | 143 |
| cefepime | 143 |
| p=0.03 | 143 |
| simplex | 143 |
| vor | 143 |
| PCD | 142 |
| Hematopoietic | 142 |
| Myocardial | 142 |
| NAVA | 142 |
| NL63 | 142 |
| NMO | 142 |
| PC | 142 |
| diffi | 142 |
| PRISMA | 142 |
| PSI | 142 |
| Pain | 142 |
| Precautions | 142 |
| Schwann | 142 |
| T0 | 142 |
| C5 | 141 |
| CRISPR | 141 |
| Immunosuppression | 141 |
| Fresenius | 141 |
| GD | 141 |
| Histopathological | 141 |
| Crit | 141 |
| Nuclear | 141 |
| Perioperative | 141 |
| Software | 141 |
| TNFα | 141 |
| Tongji | 141 |
| Zhao | 141 |
| 18F | 140 |
| BSA | 140 |
| Excel | 140 |
| ML | 140 |
| Medicines | 140 |
| Pacific | 140 |
| RYGB | 140 |
| RC | 140 |
| Romania | 140 |
| Radiation | 140 |
| Tc-99 | 140 |
| amantadine | 140 |
| aus | 140 |
| microRNA | 140 |
| ow | 140 |
| Sleep | 140 |
| SNR | 139 |
| CFRD | 139 |
| CIS | 139 |
| Haplo | 139 |
| Il | 139 |
| Incidence | 139 |
| Jahren | 139 |
| Saint | 139 |
| Shock | 139 |
| Vietnam | 139 |
| Wilms | 139 |
| Zhejiang | 139 |
| tetracycline | 139 |
| μmol | 139 |
| PTEN | 138 |
| ADV | 138 |
| Daily | 138 |
| EPI | 138 |
| FH | 138 |
| FNA | 138 |
| Geneva | 138 |
| Hand | 138 |
| Lymphopenia | 138 |
| Organisation | 138 |
| sirolimus | 138 |
| faecalis | 138 |
| lamivudine | 138 |
| iv | 138 |
| pancytopenia | 138 |
| exosomes | 138 |
| Universitario | 138 |
| TMP | 138 |
| Southern | 138 |
| Covid | 137 |
| AU | 137 |
| Andrea | 137 |
| Approach | 137 |
| Aspergillus | 137 |
| BMD | 137 |
| Burden | 137 |
| Carlo | 137 |
| Daniel | 137 |
| E2 | 137 |
| Emerging | 137 |
| Resistance | 137 |
| SMX | 137 |
| Wei | 137 |
| zwischen | 137 |
| Rankin | 137 |
| Jahre | 136 |
| MO | 136 |
| NIRS | 136 |
| DLCO | 136 |
| CAC | 136 |
| -2 | 136 |
| Miller | 136 |
| KIR | 136 |
| NSAID | 136 |
| TME | 136 |
| Tehran | 136 |
| herpes | 136 |
| paciente | 136 |
| ° | 136 |
| RFLP | 136 |
| Indian | 135 |
| Advanced | 135 |
| CTP | 135 |
| DL | 135 |
| Dawley | 135 |
| Hu | 135 |
| IL6 | 135 |
| MEDLINE | 135 |
| MMR | 135 |
| Microsoft | 135 |
| OD | 135 |
| Orthopaedic | 135 |
| Rep | 135 |
| Richard | 135 |
| SAP | 135 |
| adenocarcinomas | 135 |
| NCP | 134 |
| African | 134 |
| CD28 | 134 |
| DTT | 134 |
| Frailty | 134 |
| GRN | 134 |
| Intervention | 134 |
| Mark | 134 |
| Identification | 134 |
| PTT | 134 |
| Toll | 134 |
| nivolumab | 134 |
| Total | 134 |
| Paediatric | 134 |
| St | 134 |
| Sjogren | 134 |
| Severity | 134 |
| Louis | 133 |
| ERK | 133 |
| Fever | 133 |
| Gilead | 133 |
| HI | 133 |
| HKU1 | 133 |
| IPA | 133 |
| IRI | 133 |
| Czech | 133 |
| LRTI | 133 |
| PAN | 133 |
| WM | 133 |
| XII | 133 |
| adefovir | 133 |
| neurosurgery | 133 |
| protein | 133 |
| zeigte | 133 |
| ≥ | 133 |
| Pugh | 133 |
| FBP | 132 |
| Multicenter | 132 |
| Michigan | 132 |
| GABA | 132 |
| Neurocritical | 132 |
| DSS | 132 |
| Corticosteroid | 132 |
| CPC | 132 |
| NSE | 132 |
| CD9 | 132 |
| Nipah | 132 |
| White | 132 |
| Outcome | 132 |
| thromboprophylaxis | 132 |
| i. | 132 |
| à | 132 |
| Veterans | 132 |
| Technologies | 132 |
| SLIT | 132 |
| Population | 132 |
| ABG | 131 |
| CAUTI | 131 |
| CFR | 131 |
| PRP | 131 |
| Disorders | 131 |
| Guide | 131 |
| HMGB1 | 131 |
| NASH | 131 |
| WG | 131 |
| R2 | 131 |
| Sci | 131 |
| Stevens | 131 |
| UCI | 131 |
| Yan | 131 |
| clarithromycin | 131 |
| doxycycline | 131 |
| RhD | 131 |
| DRB1 | 130 |
| GIST | 130 |
| GB | 130 |
| FAS | 130 |
| Ali | 130 |
| Comparison | 130 |
| CTLA-4 | 130 |
| Busulfan | 130 |
| IL-3 | 130 |
| Han | 130 |
| MIP | 130 |
| Newcastle | 130 |
| Nosocomial | 130 |
| Personal | 130 |
| Programme | 130 |
| RHCE | 130 |
| Sprague | 130 |
| ces | 130 |
| obliterans | 130 |
| tratamiento | 130 |
| IMA | 129 |
| Antonio | 129 |
| BiPAP | 129 |
| Cleveland | 129 |
| Diego | 129 |
| Equipment | 129 |
| Home | 129 |
| ARI | 129 |
| Laboratories | 129 |
| OC | 129 |
| R0 | 129 |
| SLN | 129 |
| Spectrum | 129 |
| Sydney | 129 |
| cmH2O | 129 |
| H&E | 128 |
| GORD | 128 |
| Epidemiological | 128 |
| Cells | 128 |
| AO | 128 |
| CIP | 128 |
| Application | 128 |
| ICD | 128 |
| ACLF | 128 |
| HIPAA | 128 |
| COV | 128 |
| Latin | 128 |
| PPI | 128 |
| Likert | 128 |
| infliximab | 128 |
| WA | 128 |
| RPT | 128 |
| Res | 128 |
| PM | 128 |
| Marco | 128 |
| MTP | 128 |
| MN | 128 |
| MPR | 127 |
| IG | 127 |
| Inhibitor | 127 |
| LSG | 127 |
| Lassa | 127 |
| Laura | 127 |
| Spectra | 127 |
| Oseltamivir | 127 |
| TRT | 127 |
| VAD | 127 |
| XLA | 127 |
| baricitinib | 127 |
| Gleason | 126 |
| AAT | 126 |
| ABL | 126 |
| Air | 126 |
| CIN | 126 |
| Co | 126 |
| FD | 126 |
| GCA | 126 |
| Palliative | 126 |
| IDO | 126 |
| PDT | 126 |
| arthralgia | 126 |
| PRT | 126 |
| ISTH | 126 |
| Occupational | 126 |
| MBP | 126 |
| NI | 126 |
| IOS | 125 |
| BPH | 125 |
| Chan | 125 |
| Coronary | 125 |
| EORTC | 125 |
| Enzyme | 125 |
| GCSF | 125 |
| GRE | 125 |
| Guangzhou | 125 |
| leukocytosis | 125 |
| Sanofi | 125 |
| mHealth | 125 |
| MetS | 125 |
| keine | 125 |
| LST | 125 |
| RFS | 125 |
| PSP | 125 |
| Nach | 125 |
| NYHA | 125 |
| Affairs | 124 |
| Arbidol | 124 |
| Core | 124 |
| Gastroenterology | 124 |
| Graz | 124 |
| Jun | 124 |
| PBM | 124 |
| MIF | 124 |
| QI | 124 |
| disease-2019 | 124 |
| kDa | 124 |
| maltophilia | 124 |
| n=15 | 124 |
| © | 124 |
| diagnóstico | 124 |
| DN | 123 |
| ATCC | 123 |
| Antibodies | 123 |
| Antiviral | 123 |
| Baltimore | 123 |
| CD44 | 123 |
| Corporation | 123 |
| CBD | 123 |
| Inflammatory | 123 |
| Natural | 123 |
| OGTT | 123 |
| microRNAs | 123 |
| ribavirin | 123 |
| waren | 123 |
| ≥2 | 123 |
| Johns | 123 |
| ETV | 122 |
| Munich | 122 |
| Memorial | 122 |
| LM | 122 |
| IMT | 122 |
| García | 122 |
| Bacteroides | 122 |
| Definition | 122 |
| COX-2 | 122 |
| CFF | 122 |
| Authority | 122 |
| OM | 122 |
| Neisseria | 122 |
| tazobactam | 122 |
| SCI | 122 |
| mAs | 122 |
| Sars | 122 |
| sobre | 122 |
| neutrophilic | 122 |
| n=11 | 122 |
| se | 122 |
| entre | 122 |
| aeruginosa | 122 |
| TSE | 122 |
| TNC | 122 |
| Singh | 122 |
| Leukemia | 121 |
| CTLA4 | 121 |
| CURB-65 | 121 |
| Campylobacter | 121 |
| FBS | 121 |
| Heidelberg | 121 |
| IBS | 121 |
| IO | 121 |
| BG | 121 |
| NADPH | 121 |
| RADS | 121 |
| tx | 121 |
| metronidazole | 121 |
| doi | 121 |
| Neurosurgery | 121 |
| PRBC | 121 |
| Oral | 121 |
| Online | 121 |
| JC | 120 |
| Caucasians | 120 |
| Disclosure | 120 |
| Dose | 120 |
| GMP | 120 |
| Guo | 120 |
| HM | 120 |
| HTN | 120 |
| IgAN | 120 |
| Anesthesiology | 120 |
| Mini | 120 |
| PAPR | 120 |
| Victor | 120 |
| Pharmaceutical | 120 |
| enfermedad | 120 |
| Vincent | 120 |
| Ϯ | 120 |
| Triage | 120 |
| Suppl | 120 |
| Sarcopenia | 120 |
| Anne | 119 |
| Dublin | 119 |
| Predictors | 119 |
| Immunoglobulin | 119 |
| Institut | 119 |
| License | 119 |
| Neurologic | 119 |
| OVA | 119 |
| IPS | 119 |
| Recovery | 119 |
| b. | 119 |
| p=0.005 | 119 |
| manejo | 119 |
| hepatosplenomegaly | 119 |
| Stage | 119 |
| Yi | 119 |
| TPO | 119 |
| Stata | 119 |
| Pfizer | 118 |
| ACD | 118 |
| CN | 118 |
| HCPs | 118 |
| Improvement | 118 |
| Mg | 118 |
| NCC | 118 |
| OB | 118 |
| PAF | 118 |
| Wong | 118 |
| Prophylaxis | 118 |
| War | 118 |
| Zhu | 118 |
| Zn | 118 |
| east | 118 |
| kV | 118 |
| review | 118 |
| rm | 118 |
| transthoracic | 118 |
| Nile | 117 |
| Down | 117 |
| Electronic | 117 |
| LN | 117 |
| NSW | 117 |
| Gr | 117 |
| Pre | 117 |
| REBOA | 117 |
| p=0.004 | 117 |
| rd | 117 |
| Professor | 117 |
| NIPPV | 116 |
| Excellence | 116 |
| Exosomes | 116 |
| Hungary | 116 |
| Inpatient | 116 |
| Luminex | 116 |
| Self | 116 |
| Tan | 116 |
| Tuberculosis | 116 |
| Urology | 116 |
| ltrates | 116 |
| riesgo | 116 |
| IL-1b | 115 |
| AMCI | 115 |
| Comprehensive | 115 |
| ERS | 115 |
| Ethical | 115 |
| Genome | 115 |
| Grundlagen | 115 |
| HPS | 115 |
| rt | 115 |
| Kaposi | 115 |
| Kinder | 115 |
| Library | 115 |
| Outpatient | 115 |
| jedoch | 115 |
| therapy | 115 |
| ‡ | 115 |
| Coronaviridae | 114 |
| IH | 114 |
| Haemophilus | 114 |
| Front | 114 |
| Federal | 114 |
| Kumar | 114 |
| CR2 | 114 |
| CMA | 114 |
| Antigen | 114 |
| Academic | 114 |
| -6 | 114 |
| IL-23 | 114 |
| Sinai | 114 |
| Malaysia | 114 |
| Sirolimus | 114 |
| OI | 114 |
| Tooth | 114 |
| Th2 | 114 |
| TI | 114 |
| agar | 114 |
| vasculopathy | 114 |
| PTC | 114 |
| PKC | 114 |
| OT | 114 |
| OSAS | 114 |
| Respir | 113 |
| Amsterdam | 113 |
| Annual | 113 |
| CTD | 113 |
| Delirium | 113 |
| Fluid | 113 |
| Lyme | 113 |
| NM | 113 |
| NPPV | 113 |
| Ortho | 113 |
| PFT | 113 |
| Ribavirin | 113 |
| Venous | 113 |
| unter | 113 |
| n=13 | 113 |
| estudios | 113 |
| clavulanic | 113 |
| histopathological | 113 |
| VWF | 113 |
| TXA | 113 |
| Sjögren | 113 |
| Scotland | 113 |
| Departments | 112 |
| Langerhans | 112 |
| LFS | 112 |
| HIV+ | 112 |
| Guangdong | 112 |
| GO | 112 |
| GG | 112 |
| Biomedical | 112 |
| DCE | 112 |
| Complement | 112 |
| Campaign | 112 |
| Birmingham | 112 |
| PDAC | 112 |
| Abs | 112 |
| NO | 112 |
| hydroxyurea | 112 |
| PDGF | 112 |
| Stress | 112 |
| submucosal | 112 |
| más | 112 |
| fMRI | 112 |
| PICC | 112 |
| TPN | 112 |
| Surviving | 112 |
| Therapeutic | 112 |
| Ringer | 112 |
| Resonance | 112 |
| Reference | 112 |
| Qiagen | 112 |
| Port | 112 |
| PL | 112 |
| Material | 111 |
| AUROC | 111 |
| Applied | 111 |
| CSE | 111 |
| Discovery | 111 |
| Dysregulation | 111 |
| H3N2 | 111 |